PULSED CURRENT AS AN INDICATOR OF SUCCESSFUL TUMOR ELECTROCHEMOTHERAPY

Veronika Malyško1, Vitalij Novickij1, Augustinas Želvys2, Austėja Balevičiūtė2, Auksė Zinkevičienė2, Jurij Novickij1, Gediminas Staigvila1, Irutė Girkontaitė2

1 Department of Electrical Engineering, Vilnius Gediminas Technical University, Lithuania

2 Department of Immunology, State Research Institute Centre for Innovative Medicine, Vilnius, Lithuania

Pulsed electric field (PEF) is used for ablation of tumors [1] or intratumoral drug delivery [2], however, the possibilities for real-time evaluation of the treatment efficacy are limited. In this work, we have used microsecond and nanosecond non-thermal PEF (<10 J) for electrochemotherapy of Sp2/0 tumors with doxorubicin and evaluated the feasibility of current measurement as an indicator of successful tumor electrochemotherapy. The changes in pulsed current amplitude during the in vivo experiments were compared to the changes of the permeabilization rate of the cells in vitro. It was shown that the current varies in a similar tendency as the permeabilization rate. It was also shown that changes in tumor conductivity can be used as an indicator of permeabilization efficiency, however, limited to non-thermal PEF treatments. The results can be used for development and optimization of electrochemotherapy protocols and techniques for real time prediction of treatment outcome.

Acknowledgments: The research was funded by Research Council of Lithuania, Grant Nr. S-MIP-19-22.


[1] Stam, Anita GM, and Tanja D. de Gruijl. "From local to systemic treatment: leveraging antitumor immunity following irreversible electroporation." Irreversible Electroporation in Clinical Practice. Springer, Cham, 249-270, (2018).

[2] Falk, H., et al. "Calcium electroporation for treatment of cutaneous metastases; a randomized double-blinded phase II study, comparing the effect of calcium electroporation with electrochemotherapy." Acta Oncologica 57.3, 311-319 (2018).